Could a simple protein infusion boost stroke recovery?
NCT ID NCT07294391
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving a protein called albumin directly into the artery during a stroke procedure can reduce brain damage. Sixty adults with a severe stroke will receive either standard treatment alone or standard treatment plus albumin. The goal is to see if albumin helps limit the size of the stroke and improves recovery at 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
human albumin (a protein in blood) given as an infusion into the artery
What this could lead to
If it works, this could point toward a simple, safe way to protect the brain after a stroke and improve recovery chances.
What could go wrong
This is a small, early-phase trial with only 60 people, so results may not apply to everyone. The benefit of albumin is unproven, and there is a risk of allergic reactions or fluid overload.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••